Clinical Pharmacokinetics

Title Publication Date Language Citations
Contributors1997/01/01English
Pharmacokinetics and Dose Proportionality of D2-Agonist MK-458 (HPMC) in Parkinsonism1992/03/01English
Current Literature References on Clinical Pharmacokinetics1981/01/01English
Pharmacokinetics of Phenylethylmalonamide (PEMA) after Oral and Intravenous Administration1983/01/01English
Current Literature References on Clinical Pharmacokinetics1976/05/01English
Single-Dose Kinetics and Dosage of Mecillinam in Renal Failure and Haemodialysis1984/01/01English
Current Literature References on Clinical Pharmacokinetics1976/01/01English
Current Literature References on Clinical Pharmacokinetics1977/01/01English
Contributors1997/01/01English
Clinical Pharmacokinetics of Phenytoin1980/01/01English
Current Literature References on Clinical Pharmacokinetics1979/01/01English
Current Literature References on Clinical Pharmacokinetics1982/01/01English
Ajmaline Test in a Patient with Chronic Renal Failure1991/08/01English
Clinical Pharmacokinetics of Digoxin1977/01/01English
Current Literature References on Clinical Pharmacokinetics1978/01/01English
Acknowledgement to Referees2017/11/13English
Author’s reply to Veloso HH Comment on “The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm”2016/03/21English
Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations2016/06/18English
Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies2023/06/01English
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease2023/05/14English
Toward Genetic Testing of Rivaroxaban? Insights from a Systematic Review on the Role of Genetic Polymorphism in Rivaroxaban Therapy2024/03/01English
Clinical Evaluation of the Effect of Encorafenib on Bupropion, Rosuvastatin, and Coproporphyrin I and Considerations for Statin Coadministration2024/02/29English
Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates2024/02/28English
Dosing of Convalescent Plasma and Hyperimmune Anti-SARS-CoV-2 Immunoglobulins: A Phase I/II Dose-Finding Study2024/03/01English
Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors2024/04/05English
Comment on “Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies” and “High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints”2024/04/04English
Relative Bioavailability of Dolutegravir (DTG) and Emtricitabine/Tenofovir Alafenamide Fumarate (F/TAF) Administered as Paediatric Tablet Formulations in Healthy Volunteers2024/04/04English
Clinical Pharmacology of the Antibody–Drug Conjugate Enfortumab Vedotin in Advanced Urothelial Carcinoma and Other Malignant Solid Tumors2024/04/01English
Pharmacokinetics of Monoclonal Antibodies Throughout Pregnancy: A Systematic Literature Review2024/04/07English
Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration2024/04/06English